E2 ModerateModerate confidencePEM not requiredObservationalPeer-reviewedReviewed
Standard · 3 min
Chronic fatigue and the chronic fatigue syndrome: prevalence in a Pacific Northwest health care system.
Buchwald, D, Umali, P, Umali, J et al. · Annals of internal medicine · 1995 · DOI
Quick Summary
This study surveyed over 3,000 people in a Seattle health plan to find out how common ME/CFS and chronic fatigue are in the community. Researchers found that about 19% of people reported chronic fatigue, but only a tiny fraction actually met the strict diagnostic criteria for ME/CFS. Those with ME/CFS or chronic fatigue had worse physical health, more difficulty with daily activities, and more emotional stress compared to healthy people without fatigue.
Why It Matters
This study provides community-based prevalence estimates for ME/CFS and chronic fatigue, demonstrating that unexplained disabling fatigue is relatively common while meeting strict ME/CFS diagnostic criteria is rare. The findings highlight the gap between the broader population experiencing debilitating fatigue and those meeting formal diagnostic criteria, which informs clinical recognition and public health planning for ME/CFS.
Observed Findings
Chronic fatigue was reported by 590 of 3,066 respondents (19%); 388 of these had an identifiable medical or psychiatric explanation.
Only 3 of 74 enrolled participants with unexplained chronic fatigue met CDC criteria for ME/CFS.
Persons with ME/CFS or chronic fatigue had significantly higher rates of cervical and axillary adenopathy compared to healthy controls.
Those with ME/CFS or chronic fatigue demonstrated poorer functional status and greater psychological distress than age- and sex-matched controls.
Demographic characteristics (age, sex, race/ethnicity) were similar across ME/CFS, chronic fatigue, and control groups.
Inferred Conclusions
ME/CFS as defined by 1994 CDC criteria is a rare condition compared to the broader category of unexplained chronic debilitating fatigue.
Chronic fatigue and ME/CFS are associated with objective clinical signs (adenopathy) and measurable functional impairment, not solely psychiatric in origin.
The estimated community prevalence of ME/CFS ranged from 75–267 per 100,000 depending on assumptions about non-responders.
Remaining Questions
What are the characteristics and outcomes of the large proportion of people with chronic fatigue who do not meet ME/CFS criteria—do they have distinct underlying pathology or simply incomplete expression of ME/CFS symptoms?
What This Study Does Not Prove
This cross-sectional study does not establish causation or explain the biological mechanisms underlying ME/CFS or chronic fatigue. The low proportion meeting ME/CFS criteria reflects the restrictiveness of the 1994 CDC definition used at the time and does not indicate that ME/CFS is rare; rather, it suggests many people with ME/CFS may not be formally diagnosed or meet alternate case definitions. Additionally, non-responders to the survey were not systematically assessed, introducing potential selection bias.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.
Why are only a small fraction of people reporting fatigue ultimately confirmed to have unexplained fatigue after medical evaluation?
Do the demographic similarities across groups suggest ME/CFS affects all populations equally, or is this finding an artifact of differential case recognition or healthcare access?
How do prevalence estimates change with alternative or updated ME/CFS case definitions beyond the 1994 CDC criteria?